Injections of anti–IL-1β antibody reduced circulating IL-1β levels (Figure 7E) but did not alter BUN levels (Supplemental Figure 11) in WT-CKD mice compared with IgG-treated mice. The gene discussed is IL1B; the disease is chronic kidney disease.